HTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedented levels of disruption due to COVID-19.
A survey of employees within pricing and market access in pharma and biotech companies together with analysis of HTA decision-making in Europe was conducted to ascertain the impact the pandemic has had on the pharmaceutical industry.
Please click here to view the poster.